Objective: To report two cases of chronic neutropenic states successfully treated with granulocyte colony stimulating factor (G-CSF)
Granulocyte-colony stimulating factor (G-CSF) is a glycoprotein, the second CSF, sharing some common...
Objective: To evaluate the effectiveness of GCSF as a secondary preventive adjunct to chemotherapy i...
man granulocyte colony-stimulating factor (G-CSF) is ef-fective in increasing neutrophil counts in p...
Background: Colony stimulating factor(CSF) has been shown to accelerate neutrophil recovery after ch...
After informed consent, 86 patients with advanced cancer undergoing potentially myelosuppressive cyt...
Chemotherapy induced neutropenic fever requires a hospitalization in 20-30 % of cases and is then as...
Hematopoietic growth factors (CSFs) are now available for use in patients with myelosuppression due ...
Hematopoietic growth factors (CSFs) are now available for use in patients with myelosuppression due ...
A number of cytokines have been used in the past two decades to reduce the complications of neutrope...
Chemotherapy-induced neutropenia is a major cause of morbidity and mortality. It frequently causes d...
Patients with glycogen storage disease type 1b (GSD-1b) have neutropenia and neutrophil dysfunction ...
Recombinant human growth factors, particularly granulocyte-macrophage colony-stimulating factor (GM-...
Severe chronic neutropenia (SCN) is defined as an absolute neutrophil (ANC) of less than 0.5 x 10(9)...
Background: Febrile neutropenia (FN) remains one of the most challenging problems in medical oncolog...
Granulocyte colony stimulating factors (G-CSFs) are natural glycoproteins produced by recombinant DN...
Granulocyte-colony stimulating factor (G-CSF) is a glycoprotein, the second CSF, sharing some common...
Objective: To evaluate the effectiveness of GCSF as a secondary preventive adjunct to chemotherapy i...
man granulocyte colony-stimulating factor (G-CSF) is ef-fective in increasing neutrophil counts in p...
Background: Colony stimulating factor(CSF) has been shown to accelerate neutrophil recovery after ch...
After informed consent, 86 patients with advanced cancer undergoing potentially myelosuppressive cyt...
Chemotherapy induced neutropenic fever requires a hospitalization in 20-30 % of cases and is then as...
Hematopoietic growth factors (CSFs) are now available for use in patients with myelosuppression due ...
Hematopoietic growth factors (CSFs) are now available for use in patients with myelosuppression due ...
A number of cytokines have been used in the past two decades to reduce the complications of neutrope...
Chemotherapy-induced neutropenia is a major cause of morbidity and mortality. It frequently causes d...
Patients with glycogen storage disease type 1b (GSD-1b) have neutropenia and neutrophil dysfunction ...
Recombinant human growth factors, particularly granulocyte-macrophage colony-stimulating factor (GM-...
Severe chronic neutropenia (SCN) is defined as an absolute neutrophil (ANC) of less than 0.5 x 10(9)...
Background: Febrile neutropenia (FN) remains one of the most challenging problems in medical oncolog...
Granulocyte colony stimulating factors (G-CSFs) are natural glycoproteins produced by recombinant DN...
Granulocyte-colony stimulating factor (G-CSF) is a glycoprotein, the second CSF, sharing some common...
Objective: To evaluate the effectiveness of GCSF as a secondary preventive adjunct to chemotherapy i...
man granulocyte colony-stimulating factor (G-CSF) is ef-fective in increasing neutrophil counts in p...